Stock News

Endurant Capital Management LP Holds Position in Boston Scientific (BSX); As Old Natl Bancorp Ind (ONB) Stock Price Declined, Personal Capital Advisors Has Cut Its Position

Personal Capital Advisors Corp decreased its stake in Old Natl Bancorp Ind (ONB) by 12.41% based on its latest 2017Q3 regulatory filing with the SEC. Personal Capital Advisors Corp sold 77,387 shares as the company’s stock declined 13.64% while stock markets rallied. The institutional investor held 545,962 shares of the major banks company at the end of 2017Q3, valued at $9.99 million, down from 623,349 at the end of the previous reported quarter. Personal Capital Advisors Corp who had been investing in Old Natl Bancorp Ind for a number of months, seems to be less bullish one the $2.68 billion market cap company. The stock increased 0.86% or $0.15 during the last trading session, reaching $17.65. About 930,042 shares traded or 20.69% up from the average. Old National Bancorp (NASDAQ:ONB) has risen 28.89% since February 19, 2017 and is uptrending. It has outperformed by 12.19% the S&P500.

Endurant Capital Management Lp increased its stake in Boston Scientific Corp (BSX) by 64.84% based on its latest 2017Q3 regulatory filing with the SEC. Endurant Capital Management Lp bought 82,800 shares as the company’s stock rose 4.02% with the market. The institutional investor held 210,498 shares of the medical and dental instruments company at the end of 2017Q3, valued at $6.14 million, up from 127,698 at the end of the previous reported quarter. Endurant Capital Management Lp who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $37.35 billion market cap company. The stock increased 0.41% or $0.11 during the last trading session, reaching $27.2. About 6.71M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since February 19, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Among 29 analysts covering Boston Scientific Corporation (NYSE:BSX), 23 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. Boston Scientific Corporation had 89 analyst reports since July 27, 2015 according to SRatingsIntel. The stock has “Outperform” rating by BMO Capital Markets on Friday, October 27. The company was maintained on Wednesday, November 29 by Jefferies. Cowen & Co maintained Boston Scientific Corporation (NYSE:BSX) on Thursday, July 27 with “Buy” rating. Jefferies maintained Boston Scientific Corporation (NYSE:BSX) on Friday, October 6 with “Hold” rating. The company was maintained on Thursday, August 31 by Needham. On Tuesday, January 9 the stock rating was maintained by Leerink Swann with “Buy”. SunTrust initiated the shares of BSX in report on Thursday, February 25 with “Buy” rating. The firm has “Buy” rating given on Wednesday, October 28 by Needham. The firm has “Hold” rating by Oppenheimer given on Friday, July 28. The rating was maintained by Citigroup on Thursday, October 6 with “Buy”.

Endurant Capital Management Lp, which manages about $127.40 million and $330.07M US Long portfolio, decreased its stake in Express Scripts Hldg Co (NASDAQ:ESRX) by 5,700 shares to 123,790 shares, valued at $7.84 million in 2017Q3, according to the filing. It also reduced its holding in Halozyme Therapeutics Inc (NASDAQ:HALO) by 21,400 shares in the quarter, leaving it with 115,500 shares, and cut its stake in Mckesson Corp (NYSE:MCK).

Since August 29, 2017, it had 0 buys, and 12 selling transactions for $16.75 million activity. $323,435 worth of stock was sold by Pratt Timothy A. on Monday, October 2. Shares for $139,104 were sold by Pierce David A. 347,137 shares valued at $10.11 million were sold by Bose Supratim on Tuesday, October 3. On Wednesday, August 30 the insider Nanavaty Maulik sold $1.56M. Fitzgerald Joseph Michael had sold 85,227 shares worth $2.26 million on Wednesday, February 7.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It is positive, as 33 investors sold BSX shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Aperio Group Incorporated Limited Liability owns 516,577 shares for 0.09% of their portfolio. Iguana Mngmt Limited Com has 125,000 shares. Citigroup holds 0.01% or 381,411 shares. Nippon Life has 62,876 shares. Alliancebernstein LP reported 2.28M shares. Advisor Partners Lc holds 26,937 shares. Suntrust Banks reported 28,073 shares stake. Arizona State Retirement stated it has 0.15% of its portfolio in Boston Scientific Corporation (NYSE:BSX). 36,210 were accumulated by Kentucky Retirement Sys Trust Fund. 13,377 are held by Enterprise Svcs Corp. 42.17 million were reported by Primecap Mngmt Ca. Tower Research Cap (Trc) owns 159 shares. American Century Incorporated reported 10.50 million shares stake. Canada Pension Plan Invest Board has 903,489 shares. Schroder Mngmt Grp Inc holds 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 253,421 shares.

Personal Capital Advisors Corp, which manages about $1.01B and $5.13B US Long portfolio, upped its stake in American Tower Corp New (NYSE:AMT) by 10,813 shares to 182,009 shares, valued at $24.88M in 2017Q3, according to the filing. It also increased its holding in L3 Technologies Inc by 13,062 shares in the quarter, for a total of 61,723 shares, and has risen its stake in Schwab Strategic Tr (SCHF).

Leave a Reply

Your email address will not be published. Required fields are marked *